饮食增强的LRG1表达促进胰腺β细胞胰岛素过度分泌和内质网应激
研究探讨饮食增强的血清富亮氨酸α-2-糖蛋白1(LRG1)是否通过直接刺激胰腺β细胞胰岛素分泌促进高胰岛素血症。人体血清样本显示LRG1与年龄和BMI正相关,且在2型糖尿病患者中升高;高脂饮食小鼠中LRG1上调与高胰岛素血症相关,Lrg1敲除可防止饮食诱导的胰岛增生和β细胞质量丢失,中和LRG1可预防高胰岛素血症并保持葡萄糖耐量。机制上LRG1通过PLC依赖性方式诱导IP3产生和内质网钙释放,导致MIN6细胞胰岛素过度分泌和内质网应激。
要点
- 人血清LRG1水平与年龄和BMI显著正相关,且在2型糖尿病患者中较无糖尿病者升高。
- 高脂饮食小鼠中血清LRG1上调与高胰岛素血症相关,Lrg1敲除可防止饮食诱导的胰岛增生和β细胞质量丢失。
- 中和LRG1活性可预防饮食诱导的高胰岛素血症并保持葡萄糖耐量。
核心结论
- 本研究将LRG1确定为高胰岛素血症和β细胞功能障碍的重要贡献者,靶向LRG1活性是应对饮食诱导的β细胞功能障碍和管理2型糖尿病的有前景的治疗方法。
研究设计与样本
- 研究获取接受整形手术个体(男性和女性)的人血清样本;雄性C57BL/6野生型和Lrg1全身敲除(Lrg1KO)小鼠喂食45%高脂饮食,每2周收集血清监测LRG1和胰岛素水平;使用MIN6 β细胞研究LRG1对胰岛素分泌和细胞内Ca2+释放的影响;使用靶向不同LRG1表位的抗体在中性化MIN6细胞中LRG1刺激,并在体内测试其预防LRG1诱导的高胰岛素血症的能力。
主要发现
- 人血清LRG1水平与年龄和BMI呈显著正相关,且在2型糖尿病患者中较无糖尿病者升高。
- 高脂饮食小鼠中血清LRG1上调与高胰岛素血症相关;Lrg1敲除保护小鼠免受饮食诱导的胰岛增生和β细胞质量丢失。
- 中和LRG1活性可预防饮食诱导的高胰岛素血症发生并保持葡萄糖耐量。
- LRG1以磷脂酶C(PLC)依赖性方式诱导三磷酸肌醇(IP3)产生和内质网Ca2+释放,导致MIN6 β细胞胰岛素过度分泌和内质网应激。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Upregulation of serum leucine-rich α-2-glycoprotein 1 (LRG1) has been implicated in diet-induced obesity and metabolic disorders. However, its specific hormonal actions remain unclear. This study aimed to determine whether diet-enhanced serum LRG1 levels promote hyperinsulinaemia by directly stimulating insulin secretion from pancreatic beta cells. METHODS: Human serum samples were obtained from individuals (both male and female) undergoing plastic surgery. Male C57BL/6 wild-type and Lrg1 whole-body knockout (Lrg1KO) mice were fed a 45% high-fat diet, with serum samples collected every 2 weeks to monitor LRG1 and insulin levels throughout diet-induced obesity. MIN6 beta cells were used to investigate the effects of LRG1 on insulin secretion and intracellular Ca2+ release. Antibodies targeting various LRG1 epitopes were used to neutralise LRG1 stimulation in MIN6 cells, and their effectiveness was tested in vivo to assess their ability to prevent LRG1-induced hyperinsulinaemia. RESULTS: We observed a significant positive association between human serum LRG1 levels and both age and BMI, with elevated levels observed in individuals with vs without type 2 diabetes. In mice fed a high-fat diet, LRG1 upregulation in serum was associated with hyperinsulinaemia. Lrg1 knockout protected mice from diet-induced islet hyperplasia and the loss of beta cell mass. Furthermore, neutralising LRG1 activity prevented the onset of diet-induced hyperinsulinaemia and preserved glucose tolerance. Mechanistically, LRG1 induces inositol triphosphate (IP3) production and intracellular Ca2+ release from the endoplasmic reticulum (ER) in a phospholipase C (PLC)-dependent manner, leading to excessive insulin secretion and ER stress in MIN6 beta cells. CONCLUSIONS/INTERPRETATION: In summary, this study identifies LRG1 as a significant contributor to hyperinsulinaemia and beta cell dysfunction. Targeting LRG1 activity emerges as a promising therapeutic approach for addressing diet-induced beta cell dysfunction and managing type 2 diabetes.
引用
- Morales DD, Ryu J, Wei C, et al. Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells. Diabetologia. 2024. PMID: 39589509. doi:10.1007/s00125-024-06331-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。